Gujarat Themis Biosyn Ltd.

Web: gtbl.in NSE: GUJTHEM BSE: 506879 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

413 12(-3%)

Volume

2L as on 19, Jun

Open

310

High

310

Low

302

425

VWAP

382

52 Week High

479

52 Week Low

225

Viand Research Rating

Quality Score

5/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

5,371

No. of Shares

10.9

P/E

68.26

P/B

16.1

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

23.59

ROCE

Profit Growth

Listing Date

Promoter Holding

70.86%

FII Holding

1.8%

DII Holding

1.17%

Price Chart

Price Performance

1 Week1%

1 Month8%

3 Months39%

6 Months29%

1 Year29%

YTD29%

Moving Average

5 Day SMA380

10 Day SMA386

20 Day SMA392

30 Day SMA384

50 Day SMA365

61 Day SMA346

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	399	377	392	398
Resistance 2	392	376	386	392
Resistance 1	382	374	382	382
Pivot Point	376	373	376	376
Support 1	366	371	370	365
Support 2	360	370	366	359
Support 3	350	368	360	349

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Feb 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 70.86%	(0.01) 70.87%	(0.01) 70.87%	(0.01) 70.87%	(0.01) 70.87%	(0.01) 70.86%	(0.01) 70.87%	(0.01) 70.87%	(0.01) 70.87%	(0.01) 70.87%	(-4.11) 70.87%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 75.00%	(0.01) 74.99%	(0.01) 74.99%	(0.01) 74.99%
FIIs	(-0.21) 1.80%	(-1.01) 1.96%	(0.41) 2.95%	(0.61) 2.51%	(0.41) 1.91%	(0.11) 1.47%	(-0.11) 1.42%	(0.11) 1.49%	(0.41) 1.44%	(0.21) 1.05%	(0.91) 0.86%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.01) 1.17%	(0.41) 1.18%	(0.81) 0.82%	(0.01) 0.04%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.03%	(0.01) 0.03%	(-0.31) 0.03%	(0.01) 0.31%	(0.01) 0.31%	(0.01) 0.31%
Public	26.15%	26.00%	25.01%	25.44%	26.05%	26.49%	26.55%	26.47%	26.52%	27.26%	28.23%	24.96%	24.95%	24.95%	24.96%	24.98%	24.69%	24.70%	24.70%
No. of Shareholders	26,886	27,325	28,319	28,945	30,673	30,695	30,934	31,271	30,280	29,576	28,655	19,846	17,373	16,804	16,550	14,904	13,830	13,917	13,059

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	44	43	42	36	38	40	35	39	42	39	40	50	28	28	48	44.94	29	19	35
Sales Growth % (YoY)	17.2%	9.7%	22%	-7.6%	-10.2%	1.9%	-12.2%	-21.7%	52.3%	37.7%	-17.1%	10.4%	-4.1%	51.4%	36.1%	38.5%	23.4%	-23.8%	28.9%
Sales Growth % (QoQ)	2.3%	2.4%	16.7%	-5.3%	-5%	14.3%	-10.3%	-7.1%	7.7%	-2.5%	-20%	78.6%	-	-41.7%	6.8%	55%	52.6%	-45.7%	-
Expenses	25	22	21	22	22	21	19	20	21	21	23	26	13	16	23	22.16	16	9	17
Operating Profit	19	21	21	14	16	19	15	19	21	18	17	24	14	12	24	22.78	13	10	18
OPM %	44	49	49	39	42	48	44	48	50	46	42	47	52	43	51	50.69	45	53	53
Other Income	1	0	1	0	1	0	0	1	1	1	1	1	2	2	1	1.42	2	1	1
Interest	2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.06	0	0	0
Depreciation	4	4	3	2	1	2	1	1	1	1	1	1	1	1	1	0.57	1	1	1
Profit before tax	14	17	19	12	16	17	14	18	21	18	17	24	16	13	25	23.57	14	10	18
Tax %	24	26	24	25	25	25	26	26	24	26	26	26	25	26	26	24.61	29	26	25
Net Profit	11	12	14	9	12	13	11	13	16	13	13	18	12	10	19	17.77	10	7	14
Net Profit Growth % (QoQ)	-8.3%	-14.3%	55.6%	-25%	-7.7%	18.2%	-15.4%	-18.8%	23.1%	-	-27.8%	50%	20%	-47.4%	6.9%	77.7%	42.9%	-50%	-
Net Profit Growth % (YoY)	-8.3%	-7.7%	27.3%	-30.8%	-25%	-	-15.4%	-27.8%	33.3%	30%	-31.6%	1.3%	20%	42.9%	35.7%	-	-	-	-
TTM Net Profit	46	47	48	45	49	53	53	55	60	56	53	59	58.77	56.77	53.77	48.77	31	21	0
EPS in Rs	1	1.14	1.31	0.83	1.1	1.19	0.97	1.21	1.46	1.19	1.15	1.63	1.07	0.9	1.72	1.63	0.9	0.65	1.27

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	166	151	170	148	115	91	85	41	39	36	33	31	30	28
Sales Growth %	10%	-11.2%	14.4%	29.2%	26.8%	6.4%	107.4%	5.8%	8.7%	9.4%	3.8%	4%	6.6%	225.7%
Expenses	90	81	91	75	57	50	53	34	33	30	27	25	24	25
Operating Profit	76	70	79	74	58	40	32	7	6	6	6	7	6	3
OPM %	46	46	46	50	51	45	37	18	16	17	19	21	21	11
Other Income	2	2	4	7	4	3	2	2	0	0	0	0	0	0
Interest	3	0	0	0	1	1	1	0	0	0	0	0	1	1
Depreciation	13	5	4	3	2	2	1	1	1	1	1	1	1	1
Profit before tax	62	66	79	77	59	41	31	8	5	5	5	5	5	1
Tax %	25	26	25	25	26	26	24	22	20	10	0	0	0	0
Net Profit	47	49	59	58	44	30	24	6	4	4	5	5	5	1
Net Profit Growth %	-4.1%	-16.9%	1.7%	31.8%	46.7%	25%	300%	50%	-	-20%	-	-	400%	-
EPS in Rs	4.28	4.48	5.43	5.32	4	2.77	2.17	0.59	0.36	0.4	0.42	0.42	0.42	0.1
Dividend Payout %	16	15	12	14	37	0	10	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	91	64	39	40	11	1	1	6	3	4	3	4	0
Cash from Investing Activity	-112	-55	-20	-30	-2	-3	-6	-1	-3	-1	0	0	-3
Cash from Financing Activity	26	-9	-13	-14	-5	2	5	-4	0	-3	-3	-3	2
Net Cash Flow	5	0	6	-4	3	0	0	1	0	0	-1	1	0

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	11	11	11	7	7	7	7	7	7	7	7	7	7	7	7
Reserves	254	237	213	194	142	96	63	35	11	5	1	-3	-8	-13	-17
Borrowings	71	30	3	3	0	1	5	8	6	1	4	3	6	9	11
Other Liabilities	41	22	21	17	17	18	14	14	8	8	9	8	9	13	17
Total Liabilities	377	301	248	221	166	122	88	64	33	20	21	15	15	16	18
Fixed Assets	162	41	42	38	33	19	19	17	15	11	11	9	10	11	12
CWIP	132	184	136	91	21	13	2	0	1	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	82	76	69	92	113	90	67	47	17	10	11	5	5	5	6
Total Assets	377	301	248	221	166	122	88	64	33	20	21	15	15	16	18

Delivery

Delivery Data: GUJTHEM

#	Date	342 29% 439	Value (Cr)	Q/T 169	Del 54	Del 32
1	4-Sep	411	25	39	48	12
2	3-Sep	425	58	99	66	38
3	2-Sep	413	71	322	90	64
4	1-Sep	420	30	87	64	19
5	31-Aug	422	29	50	37	10
6	28-Aug	411	9	34	58	5
7	27-Aug	412	19	36	54	10
8	26-Aug	421	34	61	53	18
9	25-Aug	405	38	46	49	19
10	24-Aug	412	49	49	53	26
11	21-Aug	381	7	43	58	4
12	20-Aug	369	3	28	51	2
13	19-Aug	372	7	42	48	3
14	18-Aug	371	10	40	46	4
15	17-Aug	351	2	43	67	2
16	14-Aug	349	1	22	49	1
17	13-Aug	347	2	32	66	1
18	12-Aug	353	1	17	64	1
19	11-Aug	362	1	21	45	1
20	10-Aug	368	4	36	49	2
21	7-Aug	356	25	43	19	5
22	6-Aug	362	1	23	51	1
23	5-Aug	356	1	32	53	1
24	4-Aug	354	2	68	86	2
25	3-Aug	357	1	45	70	1
26	31-Jul	358	1	24	62	1
27	30-Jul	352	1	24	73	1
28	29-Jul	357	1	25	57	0
29	28-Jul	356	1	25	56	0
30	27-Jul	361	1	24	58	1
31	24-Jul	360	1	24	51	1
32	23-Jul	356	3	28	41	1
33	22-Jul	352	2	23	61	1
34	21-Jul	365	1	22	48	0
35	20-Jul	364	1	31	56	1
36	17-Jul	370	3	35	55	1
37	16-Jul	370	2	21	46	1
38	15-Jul	372	3	20	46	1
39	14-Jul	372	2	27	57	1
40	13-Jul	382	5	36	39	2
41	10-Jul	379	7	67	78	5
42	9-Jul	375	1	31	51	1
43	8-Jul	366	3	27	58	2
44	7-Jul	377	1	16	62	1
45	6-Jul	385	2	25	51	1
46	3-Jul	386	5	37	46	2
47	2-Jul	396	3	34	50	1
48	1-Jul	396	4	38	51	2
49	30-Jun	398	5	40	63	3
50	29-Jun	384	3	36	41	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	5,371c	181c	3.26
03-Sep	5,552c	958c	20.85
01-Sep	4,595c	92c	1.96
31-Aug	4,687c	211c	4.71
27-Aug	4,476c	134c	2.90
26-Aug	4,609c	163c	3.68
25-Aug	4,446c	22c	0.49
24-Aug	4,468c	417c	10.30
21-Aug	4,050c	3c	0.08
19-Aug	4,054c	29c	0.72
18-Aug	4,083c	230c	5.97
17-Aug	3,853c	41c	1.09
14-Aug	3,812c	11c	0.30
13-Aug	3,823c	23c	0.61
12-Aug	3,847c	179c	4.44
11-Aug	4,025c	0	0
10-Aug	4,025c	113c	2.90
07-Aug	3,912c	37c	0.92
06-Aug	3,948c	113c	2.94
04-Aug	3,836c	71c	1.83
31-Jul	3,907c	28c	0.72
30-Jul	3,879c	25c	0.64
29-Jul	3,904c	34c	0.89
28-Jul	3,870c	95c	2.40
27-Jul	3,965c	0	0

Stock Checklist

Price is above from 52 week high low average: 74%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹90 Cr · 0 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	4	1.72%	-0.50%	89.8
Bandhan Mutual Fund	2	0.10%	-	0

Gujarat Themis Biosyn Ltd.

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements